OWL Genomics > Partners and collaborators

Partners and collaborators

OWL Genomics has an extended network of partners and collaborators with scientific institutions, hospitals, biotechnology and pharmaceutical companies:

 

  • CIC bioGUNE

    CIC bioGUNE

    OWL Genomics is located in the BioGUNE Collaborative Research Centre, one of the main organizations of the BIOBASK 2010 strategy. The association between OWL Genomics and CIC bioGUNE is supporting the objective of CIC bioGUNE: promoting interactions between public research groups and commercial R+D laboratories.

    View web

  • CIC bioMAGUNE

    CIC bioMAGUNE

    Owl Genomics collaborates with CIC bioMAGUNE on new research programs in the interface between chemistry, physics and biology, with particular emphasis on the properties and applications of molecular-level biological nanostructures.

    View web

  • Gregorio Marañón Hospital

    Gregorio Marañón Hospital

    This hospital has remarkable technological facilities, along with an important educational area and research experience, and qualified and dedicated personnel. Adaptability to change and coordination with Social and Health Institutions are the most remarkable challenges. OWL Genomics is dynamically collaborating with the hepatologist Dr. Clemente in the identification of genomic signatures of hepatic pathologies, such as NASH, steatosis, cirrhosis or hepatitis.

    View web

  • UPV/EHU

    UPV/EHU

    OWL Genomics collaborates with Basque Country University in the design and the implementation of the Master in Molecular Biology and Biomedicine. Some subjects related to Metabolomics were designed and are given by OWL Genomics experts. (Cellular and molecular basis of Liporegulation).

    View web

  • Clínic Hospital in Barcelona

    Clínic Hospital in Barcelona

    OWL Genomics has set up a collaboration with the Clinic Hospital in Barcelona to develop new diagnosis systems. Hospital Clínic de Barcelona is one of the best medical assistance centers in Spain and the first one in scientific production. It´s divided in services and institutions by medical specialities and provides outstanding patient-based quality assistance, first level biomedical investigation and top quality teaching dedication in order to bring out excellent professionals. It has the objective of providing society with humanized, state of the art medicine.

    View web

  • Foundation for the Applied Medical Research (FIMA) of the University of Navarra (UNAV)

    Foundation for the Applied Medical Research (FIMA) of the University of Navarra (UNAV)

    OWL Genomics collaborates with FIMA in /"Project NASH" studying the proteins that have been differentially translated during the development of non-alcoholic steatohepatitis (NASH). At present, this collaboration includes other diseases, such as Multiple Sclerosis.

    View web

  • Noraybio

    Noraybio

    OWL Genomics and NorayBio are developing together products that will improve the MetilGenomics platform.

    View web

  • Príncipe de Astúrias Hospital in Alcalá de Henares

    Príncipe de Astúrias Hospital in Alcalá de Henares

    OWL Genomics has established a collaboration with the Principe de Asturias Hospital in Alcala de Henares to centralize and handle the hepatic tissue and serum samples from patients diagnosed with liver diseases in different stages which would allow to validate the diagnostic markers and therapeutic drugs.

    View web

  • PROGENIKA Group (Progénika, Proteómika and Abyntek Biopharma)

    PROGENIKA Group (Progénika, Proteómika and Abyntek Biopharma)

    OWL Genomics and Progenika are collaborating together in projects related to the liver (NASH, steatosis) linked by a common goal: the identification and validation of diagnostic and prognostic biomarkers, as well as potential therapeutic targets.

    View web

  • KB Data Mining

    KB Data Mining

    KB Data Mining is a small company located in San Sebastian Technology Park focused on "Omic" sciences general data processing. OWL Genomics and KB Data Mining collaboration is based on metabolomic data processing and adapting.

    View web

  • Noscira

    Noscira

    Former Neuropharma, this company is part of the Zeltia Group. It is a biopharmaceutical company devoted to the research and development of innovative drugs for the treatment and prevention of diseases of the nervous system and it is currently developing two new products for the treatment of Alzheimer's disease. OWL collaborates with Noscira in a CENIT Project aiming to apply metabolomics technology to those two products.

    View web

  • Cross Road Biotech

    Cross Road Biotech

    CRB is a venture-capital company focused on searching, selecting and investing in R+D developments for the creation and management of biotech companies in life science. CRB's mission is to drive the creation of a business framework, with high added value, through the transformation of the opportunities presented by scientific research in biotechnology, into profitable businesses. CRB is Founder Member and major shareholder of OWL Genomics.

    View web

  • Digna Biotech

    Digna Biotech

    Digna Biotech is a biotechnological company dedicated to the development and exploitation of the research products generated by the Center of Applied Medical Research (CIMA) in Pamplona. OWL Genomics has reached an agreement with Digna Biotech to develop therapeutic and diagnostic applications for great prevalence diseases.

    View web

Back to top

 

Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
Phone: +34 94 431 85 40
Fax: +34 94 431 71 40

With this web OWL Genomics intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a qualified
physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 09/06/2010

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.